← Back

UK MHRA · UK · 9 Oct 2026 · Guidance

MHRA Real-World Evidence: knowledge and guidance

AI-generated summary

The MHRA has created a knowledge and guidance hub on real-world data and real-world evidence for use in UK regulatory decision-making for medicines and medical devices. The hub compiles MHRA guidance, publications and resources for researchers, healthcare professionals, industry, patients and other stakeholders. The MHRA defines real-world data as information on patient health status or healthcare delivery collected outside clinical studies, and real-world evidence as the analysed results of such data.

From UK MHRA

Supporting guidance, publications and resources on the use of real-world data (RWD) and real-world evidence (RWE) in regulatory decision-making for medicines and medical devices in the UK.

The Real-World Evidence Knowledge and Guidance Hub brings together Medicines and Healthcare products Regulatory Agency (MHRA) guidance, publications and resources relating to the use of RWD and RWE in regulatory decision-making in the UK. This hub is intended to provide a source of information for researchers, healthcare professionals, industry, patients and other stakeholders interested in the generation and use of RWE.

The MHRA defines RWD as data relating to patient health status or delivery of health care collected outside of a clinical study. When RWD are analysed, the information produced may be referred to as real-world evidence (RWE).

Excerpt from the official page. The original is authoritative.